Cargando…
Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
OBJECTIVE: To test the hypothesis that core and suggestive features in possible dementia with Lewy bodies (DLB) would vary in their ability to predict an abnormal dopamine transporter scan and therefore a follow-up diagnosis of probable DLB. A further objective was to assess the evolution of core an...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027811/ https://www.ncbi.nlm.nih.gov/pubmed/27511183 http://dx.doi.org/10.1212/WNL.0000000000003076 |
_version_ | 1782454300743565312 |
---|---|
author | Walker, Zuzana Moreno, Emilio Thomas, Alan Inglis, Fraser Tabet, Naji Stevens, Tim Whitfield, Tim Aarsland, Dag Rainer, Michael Padovani, Alessandro |
author_facet | Walker, Zuzana Moreno, Emilio Thomas, Alan Inglis, Fraser Tabet, Naji Stevens, Tim Whitfield, Tim Aarsland, Dag Rainer, Michael Padovani, Alessandro |
author_sort | Walker, Zuzana |
collection | PubMed |
description | OBJECTIVE: To test the hypothesis that core and suggestive features in possible dementia with Lewy bodies (DLB) would vary in their ability to predict an abnormal dopamine transporter scan and therefore a follow-up diagnosis of probable DLB. A further objective was to assess the evolution of core and suggestive features in patients with possible DLB over time depending on the (123)I-FP-CIT SPECT scan result. METHODS: A total of 187 patients with possible DLB (dementia plus one core or one suggestive feature) were randomized to have dopamine transporter imaging or to follow-up without scan. DLB features were compared at baseline and at 6-month follow-up according to imaging results and follow-up diagnosis. RESULTS: For the whole cohort, the baseline frequency of parkinsonism was 30%, fluctuations 29%, visual hallucinations 24%, and REM sleep behavior disorder 17%. Clinician-rated presence of parkinsonism at baseline was significantly (p = 0.001) more frequent and Unified Parkinson’s Disease Rating Scale (UPDRS) score at baseline was significantly higher (p = 0.02) in patients with abnormal imaging. There was a significant increase in UPDRS score in the abnormal scan group over time (p < 0.01). There was relatively little evolution of the rest of the DLB features regardless of the imaging result. CONCLUSIONS: In patients with possible DLB, apart from UPDRS score, there was no difference in the evolution of DLB clinical features over 6 months between cases with normal and abnormal imaging. Only parkinsonism and dopamine transporter imaging helped to differentiate DLB from non-DLB dementia. |
format | Online Article Text |
id | pubmed-5027811 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-50278112016-09-27 Evolution of clinical features in possible DLB depending on FP-CIT SPECT result Walker, Zuzana Moreno, Emilio Thomas, Alan Inglis, Fraser Tabet, Naji Stevens, Tim Whitfield, Tim Aarsland, Dag Rainer, Michael Padovani, Alessandro Neurology Article OBJECTIVE: To test the hypothesis that core and suggestive features in possible dementia with Lewy bodies (DLB) would vary in their ability to predict an abnormal dopamine transporter scan and therefore a follow-up diagnosis of probable DLB. A further objective was to assess the evolution of core and suggestive features in patients with possible DLB over time depending on the (123)I-FP-CIT SPECT scan result. METHODS: A total of 187 patients with possible DLB (dementia plus one core or one suggestive feature) were randomized to have dopamine transporter imaging or to follow-up without scan. DLB features were compared at baseline and at 6-month follow-up according to imaging results and follow-up diagnosis. RESULTS: For the whole cohort, the baseline frequency of parkinsonism was 30%, fluctuations 29%, visual hallucinations 24%, and REM sleep behavior disorder 17%. Clinician-rated presence of parkinsonism at baseline was significantly (p = 0.001) more frequent and Unified Parkinson’s Disease Rating Scale (UPDRS) score at baseline was significantly higher (p = 0.02) in patients with abnormal imaging. There was a significant increase in UPDRS score in the abnormal scan group over time (p < 0.01). There was relatively little evolution of the rest of the DLB features regardless of the imaging result. CONCLUSIONS: In patients with possible DLB, apart from UPDRS score, there was no difference in the evolution of DLB clinical features over 6 months between cases with normal and abnormal imaging. Only parkinsonism and dopamine transporter imaging helped to differentiate DLB from non-DLB dementia. Lippincott Williams & Wilkins 2016-09-06 /pmc/articles/PMC5027811/ /pubmed/27511183 http://dx.doi.org/10.1212/WNL.0000000000003076 Text en © 2016 American Academy of Neurology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially. |
spellingShingle | Article Walker, Zuzana Moreno, Emilio Thomas, Alan Inglis, Fraser Tabet, Naji Stevens, Tim Whitfield, Tim Aarsland, Dag Rainer, Michael Padovani, Alessandro Evolution of clinical features in possible DLB depending on FP-CIT SPECT result |
title | Evolution of clinical features in possible DLB depending on FP-CIT SPECT result |
title_full | Evolution of clinical features in possible DLB depending on FP-CIT SPECT result |
title_fullStr | Evolution of clinical features in possible DLB depending on FP-CIT SPECT result |
title_full_unstemmed | Evolution of clinical features in possible DLB depending on FP-CIT SPECT result |
title_short | Evolution of clinical features in possible DLB depending on FP-CIT SPECT result |
title_sort | evolution of clinical features in possible dlb depending on fp-cit spect result |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027811/ https://www.ncbi.nlm.nih.gov/pubmed/27511183 http://dx.doi.org/10.1212/WNL.0000000000003076 |
work_keys_str_mv | AT walkerzuzana evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult AT morenoemilio evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult AT thomasalan evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult AT inglisfraser evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult AT tabetnaji evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult AT stevenstim evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult AT whitfieldtim evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult AT aarslanddag evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult AT rainermichael evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult AT padovanialessandro evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult |